Cresco Labs (CRLBF) Long-Term Deferred Tax (2019 - 2026)
Cresco Labs' (CRLBF) quarterly Long-Term Deferred Tax came in at $13.6 million in Q1 2026, up 5.58% YoY from $12.9 million in Q1 2025, and up 1.09% on a QoQ basis from $13.5 million in Q4 2025.
Cresco Labs (CRLBF) Long-Term Deferred Tax (2019 - 2026) Analysis & Trends
Cresco Labs (CRLBF) has 8 years of Long-Term Deferred Tax data on file, last reported at $13.6 million in Q1 2026.
- Quarterly Long-Term Deferred Tax rose 5.58% year-over-year to $13.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.6 million (up 5.58% YoY) and the FY2025 annual result came in at $13.5 million, up 2.85% from the prior year.
- Long-Term Deferred Tax advanced to $13.6 million in Q1 2026, from $13.5 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $17.6 million in Q2 2024 to a low of $26000.0 in Q4 2022.
- A 5-year average of $10.7 million and a median of $12.4 million in 2025 frame the typical range for Long-Term Deferred Tax.
- Annual changes were most pronounced in 2022 — Long-Term Deferred Tax tumbled 99.6% — and 2023, when it soared 44311.54%.
- Tracing CRLBF's Long-Term Deferred Tax over 5 years: stood at $26000.0 in 2022, then soared by 44311.54% to $11.5 million in 2023, then rose by 13.68% to $13.1 million in 2024, then rose by 2.85% to $13.5 million in 2025, then increased by 1.09% to $13.6 million in 2026.
- The last three Long-Term Deferred Tax figures came in at $13.6 million (Q1 2026), $13.5 million (Q4 2025), and $12.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | Cresco Labs | 295.09 Mn | 230.98 Mn | 86.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.65 Mn |
| Dec 31, 2025 | 13.50 Mn |
| Sep 30, 2025 | 12.37 Mn |
| Jun 30, 2025 | 12.77 Mn |
| Mar 31, 2025 | 12.93 Mn |
| Dec 31, 2024 | 13.13 Mn |
| Sep 30, 2024 | 16.92 Mn |
| Jun 30, 2024 | 17.61 Mn |
| Mar 31, 2024 | 10.73 Mn |
| Dec 31, 2023 | 11.55 Mn |
| Sep 30, 2023 | 9.42 Mn |
| Jun 30, 2023 | 16.16 Mn |
| Mar 31, 2023 | 237,000.00 |
| Dec 31, 2022 | 26,000.00 |
| Sep 30, 2022 | 7.87 Mn |
| Jun 30, 2022 | 6.31 Mn |
| Mar 31, 2022 | 6.00 Mn |
| Dec 31, 2021 | 6.56 Mn |
| Sep 30, 2021 | 17.20 Mn |
| Mar 31, 2021 | 8.65 Mn |